Tag: Covid-19 clinical trials

Baricitinib

Lilly starts phase 3 clinical trial with Baricitinib for hospitalized Covid-19...

0
Eli Lilly and Company announced that the first patient had been enrolled in Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and...

This function has been disabled for HealthTekPak.

error: Content is protected !!